Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. NC0432312

Selleck Chemical LLC Ralimetinib dimesylate 5mg 862507-23-1 LY2228820 dimesylate
SDP

Catalog No. NC0432312
Encompass_Preferred

Ralimetinib (LY2228820) dimesylate is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2. *For Research & Development use only.  Product is not intended for drug, household, or human consumption.

Catalog No. NC0432312 Supplier Selleck Chemical LLC Supplier No. S14945MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Ralimetinib (LY2228820) dimesylate is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2. *For Research & Development use only.  Product is not intended for drug, household, or human consumption.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.